First VL human case in Brazil was reported in 1913, when Migone identified amastigotes forms in necropsy materials collected from a man from Boa Esperança, Mato Grosso state (Brasil, 2006) . Until the 90`s, the main reported VL cases in human were from Northeast states. However, the recent and fast VL expansion to the Southeast, Midwest and North states has being verified. Northeast states presented the greatest number of VL cases in 2001 (81.7%), followed by North regions (8.8%), Southeast (7.6%) and Midwest (1.9%). However, in 2003, the disease was reported in 58%; 15%; 7% and 19% of the Northeast; North; Midwest and Southeast states, respectively, demonstrating VL urbanization in Brazil (Silva et al., 2001b; Lindoso & Goto, 2006) . Canine visceral leishmaniasis (CVL) prevalence is also high in Brazil, ranging 1% to 36% according to Brazilian region (Silva et al., 2001b) . Araçatuba was the first city in Sao Paulo state where CVL was diagnosed (Luvizotto et al., 1999) . Forty one cities in Sao Paulo state present the CVL transmission, and human VL transmission was reported in 28 cities, with 10% to 15% prevalence levels .
Vectors
The vectors related with Leishmania dispersion are phlebotomines (mainly Lutzomyia longipalpis). Fleas and ticks are considered other possible leishmaniasis vectors. Reservoirs are infected by phlebotomine females biting during its blood feeding in the skin or the peripheral blood of the reservoirs (mainly in dogs).
On the other hand, Leishmania can be also identified in wild animals as foxes (mainly Lycalopex vetulus and Cerdocyon thous) (De Lima et al., 2006) , and opossums (Didelphis albiventris) (Santiago et al., 2007) . Equines, cats and rodents have been also identified as reservoirs.
Cats are susceptible to both VL and integumentary leishmaniasis. Xenodiagnosis studies with experimental Leishmania infections in cats demonstrated the evidence of feline`s infectivity to the vector L. longipalpis. Skin lesions and protozoan distribution in organs were verified in infected cats, but the disease was self-limited after few months post-infection. Cats' eclectic habit as well as the vectors adaptation to different animal species would be favorable factors for VL transmission (Dantas-Torres et al., 2006) . VL in cats may be also associated with immunosuppressive diseases such as leukemia and feline immunodeficiency. Recent studies are been developed in order to investigate the real feline role on VL epidemiology: if they are important reservoirs or only accidental hosts.
Leishmania life cycle
Infected vertebrate hosts (reservoirs) are bitted by phlebotomine vectors during the blood feeding. Vectors acquire macrophages containing Leishmania amastigotes forms which multiply by binary division. Amastigotes differentiate to promastigote (flagellar) forms which colonize vectors` pharynges and esophagus and stay adhered to epithelium by their flagella. Then, these promastigotes forms differentiate to metacyclical promastigotes (infecting) forms.
Biological cycle is completed when vectors bite new vertebrate hosts and the infecting Leishmania forms are inoculated in the hosts` epidermis and phagocyted by macrophages. After phagocytosis, promastigotes change to amastigotes which intensively multiply by binary division. Macrophages become devitalized and break and release the amastigotes which are phagocyted by new macrophages in a continuous process. The haematogenic and lymphatic dissemination of protozoa for other tissues and organs occurs especially in mononuclear phagocytical system cells (Ikeda-Garcia & Marcondes, 2007) .
Characteristics and risk factors
VL has been considered as a re-emergent disease in some countries and has assumed a new profile due economic and social changes in the two last decades. Initially, VL was considered a typical and sporadically agricultural disease (Nunes et al., 2001) . It reached dogs and human beings that lived in close contact with forest regions (Gontijo & Melo, 2004) . However, VL has been pointed currently as a re-emergent zoonosis, characterizing a clear process of epidemiological transition. LV has become an urban endemic disease that represents serious problems for Public Health due its zoonotic potential. The frequent deforestation has reduced the availability of original wild animals to vector. Then, dogs and human actually represents alternative sources for vector`s feeding (Desjeaux, 2004) .
This zoonosis has demonstrated an increased prevalence in recent years, not only considering the number of registered cases, but also regarding its geographic distribution. The important social, political and environmental damages (Fig. 1) , added to continuous population migrations for urban centers without sanitary structure (Fig. 2) and lack of educative programs, associated to the easy vector adaptability to new environments and to the high population of dogs which are potential reservoirs, had contributed to establish favorable conditions to the VL urbanization . Reduction of the disease ecological space is also verified, leading to important outbreaks. This situation may represent a risk for vector multiplication and VL transmission to both human and animals, especially in tropical countries.
Susceptibility
People of both sexes and all ages are susceptible to VL. However, the incidence is highlighted in children with nine years of age or less, and in immunossupressed individuals. On the other hand, in recent endemic areas, a new situation regarding VL susceptibility has been observed, and the number of VL cases in children and adults is practically the same. This fact could be related to the protozoa`s pathogeny/pathogenicity variations and also to immunossupressor influences which adult persons are continuously exposed, like stress.
Approximately 12 million of people in the world are infected by Leishmania and about 1.5-2 million new cases (25-50% as VL type) are notified by year. However, the official data does not represents the real number of cases, due passive detections, under-diagnosticated cases, asymptomatic cases and low number of countries with obligatory notification (only 32 of 88 endemic countries demand obligatory cases registration). In accordance with the Regional Program of Leishmaniasis, all American countries registered more than 5,000 VL cases in 2006.
Clinical signs in human and treatment
The incubation period of VL in human is variable, ranging from 10 days to 24 months, with average of two to six months. Clinical manifestations of the disease in humans are presented gradually, starting with apathy, weight loss, anemia, fever and lymphadenopaty, and liver and spleen enlargement. Pneumonia and other severe manifestations due secondary www.intechopen.com Zoonosis 268 bacterial infections are also related. VL can be lethal in approximately 95% of cases without treatment (Murray et al., 2005) .
Treatment of human cases also is recommended as VL control method. The pentavalent antimonial substances (sodium estibogluconate and N-metil glucamine antimoniate) are the election drugs for use in humans, since 70 years ago. In India, where 50% of the VL cases occur, the miltefosin is being used -since March of 2002 -administered by oral route, also indicated in oncology. This drug presents relatively efficient safety and allows up to 98% of cure. It is indicated in refractory cases to the therapy with conventional antimoniates. However, the patients can develop gastric, intestinal and theratogenic collateral effects. Amphotericin B is another therapeutic option that also determines collateral effects and is considered a high cost drug.
HIV-VL co-infection
More than 30 million people in the world are infected by HIV, and at least one third of this population lives in leishmaniasis endemic areas (WHO). The overlapping of geographic areas where leishmaniasis and HIV occur is due to the process of urbanization.
In Europe, 70% of LV cases in adults are associated with HIV, and more than 9% of the individuals with AIDS suffer a just acquired or reactivated leishmaniasis. Users of intravenous drugs are considered of high risk for the co-infection, by sharing needles. From 80's on, this co-infection started to be described in the Europe, particularly in Spain, Italy and South France. In people infected by HIV, leishmaniasis presents severe clinical manifestations and determines lethal immunosuppressive synergism with HIV with stimulation of the viral response. However, the opportunistic behavior of Leishmania on HIV-VL co-infection is still not clear.
The HIV-VL co-infection is considered a world priority by WHO. In this context, it was established a worldwide network of further notification of cases.
Clinical signs in dogs
Canine Visceral Leishmaniasis (CVL) determines a chronic systemic disease with several clinical manifestations, with difficult diagnosis. CVL incubation period is variable. Clinical signs can be verified in dogs between three months to various years after infection (mean three to seven months) (Brasil, 2006) . Lymphadenopathy; abdominal distension due liver and spleen enlargement; skin lesions and/or alopecia (Fig. 3) ; emaciation; apathy; ocular lesions (Fig. 4) ; onicogryphosis; haemorrhages; diarrhoea and pneumonia are the main clinical signs reported. Locomotors and neurological alterations are occasionally related (Slappendel & Ferrer, 1998) .
Clinical signs in dogs may have different presentations, depending on the region (Cruz, 2006; Duprey et al., 2006; Albuquerque et al., 2007) . In a recent study, the main clinical manifestations observed in 100 examined dogs from an endemic VL area in Brazil were: emaciation (60%); spleen enlargement (57%); alopecia (51%); ocular lesions (46%); skin ulcers (43%); liver enlargement (38%); onicogryphosis (37%) and lymphadenopaty (21%) (Troncarelli et al., 2008) .
Symptomatic CVL is frequently reported, but asymptomatic cases represent about 60% of infected dogs. Asymptomatic parasited dogs with or without antibodies have been identified in natural and experimental infections (Farrel, 2002) .The infected asymptomatic animals represent a serious problem for public health because they are important unidentified reservoirs. On the other hand, when an infected asymptomatic dog is diagnosed, control measures may be difficult because the euthanasia is usually not authorized by dog's owner. 
Diagnosis

Dogs
Considering that VL is a further notification zoonosis and reinforcing the risks to public health represented by Leishmania infected dogs, CVL diagnosis must be the more accurate than possible. It is important that the technical groups involved on CVL diagnosis specifically know about the available tests, as its limitations and clinical interpretation (Luz et al., 2001; Gradoni, 2002; Ikeda-Garcia & Marcondes, 2007) .
The diagnosis result must not be individually analyzed. There are various dependent factors that must be evaluated, like epidemiological issues, clinical signs, laboratory diagnosis results, etc. A positive result, if punctually analyzed, can condemn a non-infected dog to the euthanasia and a negative result if not correctly evaluated can contribute to the maintenance of an infected dog as a Leishmania reservoir (Machado, 2004; Zivicnjak et al., 2005) .
Serology
Detection of circulating antibodies anti-Leishmania spp. in dogs by serological tests is an essential tool for CVL diagnosis. Serum samples or eluted blood samples can be examined by serological tests (Fig. 5) .
Dogs generally present seroconvertion after three months post-infection. Antibodies titles remain high for at least two years after Leishmania infection (Ikeda-Garcia & Marcondes, 2007) . CVL clinical signs and antibodies titers are not necessarily dependent factors (Reis, 2001; Ferreira et al., 2007) . (Brasil, 2006) determined that the official labs must apply ELISA as a selection diagnosis and IFAT as a confirmatory test, in CVL surveillances.
IFAT usually shows high sensitivity and specificity values, ranging from 68 to 100% and 74 to 100%, respectively (Grosjean et al., 2003; Alves & Bevilacqua, 2004) . ELISA` sensitivity and specificity values range from 71 to 100% and 85 to 100%, respectively. These tests are feasible, fast and inexpensively executed (Ikeda-Garcia & Marcondes, 2006) . However, a positive result may not represent an active disease and also infected dogs may have negative results by serological tests. Two tests with 21-30 days interval are recommended.
Due to the phylogenetic similarity between Leishmania genus and Trypanosoma cruzi (T. cruzi), serological cross-reactions (Fig. 6 ) and false-positive results are quite common (Zanette et al., 2006) . There are endemic areas, especially in the Americas, where Leishmania spp. and T.cruzi incidences are superposed and co-infection with the two parasites may occur both in dogs and in human beings (Savani et al., 2005; Madeira et al., 2006) . In fact, the results from serological tests may show Leishmania spp. and T.cruzi antibodies, signifying the occurrence of infection by the two parasites, rather than cross-reactions (Grosjean et al., 2003; Rosypal et al., 2007) . By this way, the improvement of diagnosis methods for the correct identification of canine infection is necessary to better comprehend the disease's status in dogs and also to contribute to its control. On the other hand, it is important to reinforce that cross-reactions between Leishmania and other tripanosomatids or different microorganisms (including Ehrlichia canis; Babesia canis;, Toxoplasma gondii or Dirofilaria immitis) can occur, producing false-positive results (Rosario, 2002; Luvizotto, 2003; Alvar et al., 2004) . The use of recombinant or purified antigens (like gp63, gp72 and gp70; rK39, rK9 and rK26) improves the sensitivity and specificity of serological tests (Rosário, 2002; Zijlstra et al., 2001 ).
Culture
Blood samples and lymph node, bone marrow and spleen aspirates can be used for VL diagnosis by culture in special medium like Liver Infusion Tryptosis (LIT); NNN and RPMI-1640 (Sundar & Rai, 2002) .
Leishmania amastigotes forms presented in original biological samples collected from vertebrate hosts modify to promastigotes (flagellar) forms in culture medium and can be visualized by optical microscope (Fig. 7) . Fig. 7 . Leishmania promastigotes forms isolated in Liver Infusion Tryptosis (LIT) medium after four weeks incubation at 27ºC. Optical microscopy 1000X.
Culture diagnosis is commonly used for researches purposes because it is a time and material-consuming method. Results are lately obtained because Leishmania presents a slow multiplication in culture media. A positive result can be verified until four months postincubation, especially in case of low parasite load presented in biological collected samples.
Parasitological identification
Citology
Leishmania amastigote forms can be visualized in lymph nodes squashes (or aspirate); bone marrow; spleen aspirate; skin biopsy; skin nodules aspirate; liver biopsy and blood squashes. Giemsa, Leishman, Wright and Panotico are the most common dyes used (Sundar & Rai, 2002) . Amastigotes forms have 2-5 µm size. For the correct diagnosis, it is necessary to observe three parasites` structures: cytoplasm, nucleous and kinetoplast (Fig. 8) . Aspirative cytology is generally used in vet clinics because it is a relatively easy and low invasive procedure. Citology sensitive values are directly related to parasite load, biological material collected, technical experience and time for slide examination (Ikeda- Garcia & Feitosa, 2006) . This test presents sensitivity levels of 58%, 70% and 96%, for lymph node, bone marrow and spleen aspirates, respectively (Zijlstra et al., 2001 ). The 100% specificity allows the indication of cytology as a gold standard method. However, negative results are not uncommon, especially in chronic and/or asymptomatic CVL cases.
Immunohistochemistry
Skin, liver and lymphoid tissues are the election materials for VL diagnosis by immunohistochemistry/immunocytochemistry (IHC). Blood squashes; cytological slides; histological and frozen tissues can also be examined (Ikeda-Garcia & Feitosa, 2006) . IHC allows retrospective studies and can be indicated for skilful exams.
Immunoglobulins conjugated to enzymes are used to identify Leishmania amastigotes forms in tissues. High sensitivity and specificity values of this method allow an accurate and fast diagnosis despite the eventual low parasites load on samples (Ikeda-Garcia & Marcondes, 2007) . Amastigotes presents a hazel-brown coloration, easily visible by conventional optical microscopy.
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Molecular diagnosis
Polymerase Chain Reaction (PCR) allows the parasite's DNA detection and does not depend on the dog's immunological and/or clinical status (Soares et al., 2005; Reithinger & Dujardin, 2007) . PCR can be used in cases of inconclusive reactions, anergy or cross reactions in serological tests, and shows sensitivity and specificity values near 100% (Lachaud et al., 2002; Gomes et al., 2007) . Blood samples (Silva et al., 2001a) ; lymph node aspirates; bone marrow aspirates; biopsy fragments (skin, liver, spleen, etc.) and any kind of biological material can be tested by PCR for Leishmania`s DNA search.
Different PCR protocols have been studied for leishmaniasis diagnosis in animals (StraussAyali et al., 2004) , human and vectors (Aransay et al., 2000) . Primers used are usually Leishmania genus-specific (Fig. 9. ) or specie-specific (Solano-Gallego et al., 2001) . Detection of more than one Leishmania species can be obtained by multiplex PCR (mPCR) protocols (Lachaud et al., 2002a,b) . Parasite load can be evaluated by real time PCR (qPCR) techniques (Nicolas et al., 2002) . The association of molecular methods with conventional diagnosis tests for VL diagnosis allows an accurate evaluation and also contributes to epidemiological and genetic studies (Singh & Sivakumar, 2003; Moreira et al., 2007) .
PCR also contributes with diagnosis elucidation, especially in case of cross reactions results by serological tests. 93.9% sensitivity and 85.8% specificity levels were obtained by PCR for leishmaniasis diagnosis in spleen and liver fragments collected from dogs in Bauru, an endemic CVL area in Brazil (Troncarelli et al., 2009) . Using the LINR4 and LIN19 (Ikonomopoulos et al., 2006) primers it was possible to identify 30 of 33 Leishmania infected dogs that were both positive for Leishmania and T. cruzi by IFAT. 
Human
VL human diagnosis is difficult, because it is generally based on clinical signs that are lately identified. VL is a chronic disease, with a long incubation period with gradual and slow clinical manifestations, in the main number of cases. Infected people just call for a doctor when clinical signs are evident like abdominal distension -due liver and spleen
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Visceral Leishmaniosis: An Old Disease with Continuous Impact on Public Health 275 enlargement, hypoproteinemia, anemia -besides progressive emaciation; pain; lymphadenopahty or other severe disorders. In these cases, the diagnosis is done, but the prognostic is reserved to bad, especially in case of young and/or immunossupressed patients (Brasil, 2006) .
Serology tests can be done, but results are questionable and normally do not depend on patient infection and/or clinical status. The intra-dermal reaction (Montenegro`s test) is usually negative in VL human cases during disease`s clinical course, but can be positive in asymptomatic individuals or after the clinical cure (Ikeda-Garcia & Marcondes, 2007) .
Culture of blood marrow aspirates and direct parasitological exam of blood marrow squashes are the main sensitive tests for human VL diagnosis, but sampling method is invasive and painful. Liver and spleen biopsy are not recommended, especially in chronic cases, due haemorrhages risks due organs enlargement caused by Leishmania infection.
Epidemiological vigilance, prophylaxis and control
Considering the difficulties of VL control and monitoring, actions are centered on the better definition of risk transmission areas. The new target is to reinforce vigilance measures in States and counties where no LV human or canine cases are related, in order to avoid or to minimize the disease transmission in these non endemic areas. In the VL endemic areas, after the epidemiological stratification, the control measures generally are individually evaluated and implemented. However, it is important that integrated measures are adopted for an effective control.
VL incidence especially in Americas is very high, but control strategies must be improved. Surveillance systems are usually inadequate and there are no sufficient human resources for diagnosis, treatment and control methods implementation. The Regional Program supported by the Global Program on leishmaniasis prevention and control prepared an action plan to be started in 2007. This plan includes a collective work for diagnosis tests standardization; strengthening of human resources; decentralization of public health programs of VL prevention and control; surveillance system improvement; strategic partnerships development and communities` involvement.
Vector control
The control strategy of this zoonosis includes: the early identification/treatment of human cases, the residual insecticides spraying in domiciles and near-house areas and add physical barriers in doors and windows in order to prevent the exposition to the vector. Photo-stables pyrethroids are usually sprayed in the human houses' walls, and animals' installations, like hen and swine houses, stables, etc; considering that these animals and its organic substances attract phlebotomines. It is important to reinforce the adequate destination of garbage, the removal of rubbish and organic substances in the near-house areas.
Control in dogs 7.2.1 Euthanasia
The identification of serologically positive dogs, followed by euthanasia (Fig. 10) is one of control measures adopted in endemic areas (Brasil, 2006) . VL coexists in dogs and humans but generally the disease in dogs precedes the occurrence of human cases. This reinforces the importance of fast diagnosis in dogs, especially in endemic areas. Dogs are considered competent and abundant reservoirs, and cohabit with humans. The impact of the control by positive dogs' elimination is very conflicting, because it is showing laborious, with doubtful effectiveness and for the veterinarians and owner's point of view. The euthanasia of seropositive dogs is frequently discussed. In recent studies, the evolution of seropositivity levels in humans, in two areas -one with elimination and another one without elimination of the seropositive dogs -were evaluated and there was no significant difference after one year of serological monitoring. However, the risk to the domestic man and to other animals -considering the importance of dog as a reservoir, and the low efficiency of therapeutical protocols for dogs -justifies, until the moment, the recommendation for euthanasia of infected dogs, as complementary method of control and prophylaxis of VL.
Collars with repellent substances
Collars impregnated with deltamethrin or other repellent substance can be associated with other control measures for VL prevention in dogs. This measure avoids dogs to be bitted by the vector.
A study done in Andradina , an endemic VL area in Sao Paulo State, Brazil, demonstrated that both CVL and human VL prevalences had decreased when a prevention program was initiated with deltamethrin collars putting in dogs. It is important to reinforce that collars were replaced each three to four months interval, in order to maintain the residual action of the repellent.
Vaccination
Vaccination is considered another control method of CVL. There are several studies regarding dogs' immunization, and the main researches' objective is to develop a safe, low cost and highly immunogenic vaccine against VL in dogs. In experimental studies, filtered proteins from Leishmania promastigotes culture stimulated high immunity in different hosts, and conferred good protection in BALB/c mice infected with L. major. In other research, it was demonstrated that the vaccine produced from promastigotes antigens of L. infantum allowed 92% of protection in dogs from endemic areas.
The Fucose Manose Ligand (FML) was the first antigenic glycoprotein approved for dogs`s immunization in Brazil. The main question regarding this vaccine was the probable difficulties to differentiate naturally infected from vaccinated animals by conventional serological tests.
A new recombinant vaccine using the A2 Leishmania antigen fragment was recently approved by Brazilian Ministry of Agriculture.
National researches institutes in Brazil are also involved on CVL vaccines development. The main effort is to produce a recombinant CVL vaccine associated with Rabies virus, to be used in national vaccination programs.
Treatment
Treatment of dogs with drugs indicated for human application is not recommended in Brazil (Brasil, 2006) . Despite several studies have been conducted demonstrating that clinical signals are minimized or eliminated after treatment, there are some controversies about the parasitological cure versus the apparent clinical cure. Some researches reinforce that dogs could remain as Leishmania reservoirs representing a public health risk.
On the other hand, CVL treatment is allowed in Spain and in other endemic countries.
Glucantime is sold for veterinary use, and the doses volume is adjusted for use in small animals. Moreover, there are some medical pet foods with low protein levels indicated for dogs with leishmaniasis, considering that CVL commonly determines hepatic and renal lesions by immune-complexes deposition.
Control difficulties
General factors
One of the biggest challenges for the strategies control improvement is the identification of each element of the epidemiological chain and its impact on VL transmission. The high prevalence of VL in endemic areas, especially in tropical countries are due environmental and climatic changes; low financial support on Health and Education programs; discontinuing of control measures; vector's adaptation to environments modified by human; vectors genetic variances; co-infection with immune-suppressor diseases like AIDS, or chemotherapy treatment; urban problems like under-nutrition, house lacking and sanitary deficiencies.
Diagnosis fails
The delay on human and canine VL diagnosis usually determines under-notification of cases and treatment fails. This may be determined by lack of information on VL by population and eventually by some health professionals contributing to VL severity increase, high mortality levels and dissemination risks. The time between sampling, diagnosis and control measures is too long (more than 80 days), determining the maintenance of infected dogs as reservoirs during several months. The strategy of seropositive dogs culling after 80 days blood sampling and diagnosis reduces in 9% the VL prevalence. If the euthanasia of seropositive dogs is done after 7 days of sampling and diagnosis, there is a 27% reduction in seroprevalence.
Vectors`characteristics
Phlebotomines are highly adaptable insects. As they multiply in organic materials, its control is very hard. The use of insecticides must be done by official agents with extremely sense, due the insecticides` residues that can prejudice the ecosystem and the environment.
It is also important to consider the potential of other species of insects and mites as VL transmitters.
Reservoirs` characteristics
Dog is generally considered a family member. Its close contact with human may represent a serious public health risk considering the VL transmission potential in endemic areas. In some situations, when an infected dog is identified by diagnosis methods, it is sent to another place by its owners, in order to avoid the dog`s euthanasia. As there is no control about dogs' transit from endemic to non endemic areas, the risk of introduction and dissemination of VL in different regions is very high.
It is also important to consider the reservoirs potential of wild animals as and the role of some domestic animals like cats on VL transmission.
Continued education
Continued education programs on VL are essential for population orientation and to establish directing global actions involving community and public health organs for the disease prevention and control. The educative actions must be implemented in schools and neighbor associations in order to provide information regarding the main VL clinical signs and the prevention methods. Responsible ownership must be emphasized because dogs' replacement levels after infected dogs' removal for euthanasia are extremely high, especially in VL endemic areas.
Conclusion
VL represents a serious Public Health challenge in the world. The high disease expansion both in number of cases and in geographic areas reinforces the necessity of effective VL monitoring and control strategies. The complexity of causal agent, the variability of reservoirs species and the vectors adaptability to different ecosystems demand systematic and integrated actions in different points of the epidemiological chain. These factors explain why leishmaniasis is an old disease with continuous impact on public health.
The improvement of diagnosis methods, the surveillance studies, the vaccine immunoprophylaxy, the systematic control of vectors, the researches for effective antimicrobials and therapeutical protocols for dogs and humans, the continued education regarding VL and responsible ownership are some measures for the VL control success.
